| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Aug 27, 2025 | Long Cast Advisers | 19.0% | -4.0% | CCRD, EEFT, MAMA, MTRX, PDEX, PESI, QRHC, RELL, RSSS | Cash, Demand Destruction, Microcaps, payments, small caps, Trade Policy, Valuations | Manager focuses on small company investing with concentrated positions in microcaps and small caps. Portfolio includes companies like CCRD, QRHC, MTRX, and RSSS with emphasis on finding undiscovered stocks trading at cheap valuations relative to expected growth and cash flow. | QRHC EEFT CCRD QRHC CCRD |
View |
| 2025 Q1 | Jun 5, 2025 | Long Cast Advisers | -20.0% | -20.0% | CCRD, GOOG, META, MTRX, PDEX, PESI, QRHC, RSSS | Concentration, Long Term, Outperformance, Price Discovery, small caps, value | Manager focuses exclusively on small company investing, seeking five-year doubles with 15% annualized returns. Portfolio concentrated in top-five positions representing 70% of holdings, with three stocks at or around 15% weightings. | PESI QRHC MTRX RSSS PDEX CCRD |
View |
| 2024 Q1 | May 7, 2024 | Long Cast Advisers | 6.0% | 16.0% | CCRD, CCRN, CTEK, DAIO, ENVX, LRCX, MTRX, PESI, PSSR, QRHC, RELL, RSSS, SNES | concentrated, Cyclical, Fundamental Analysis, small caps, Turnarounds, value | Manager focuses exclusively on small companies that are barely included in any indices, using fundamental analysis to evaluate financial statements and corporate strategies. The concentrated approach targets well-researched small companies offering compelling opportunities for high returns through long-term cash earnings analysis. | View | |
| 2025 Q3 | Nov 24, 2025 | Long Cast Advisers | 4.0% | -1.0% | MAMA, MTRX, PDEX, PESI, QRHC, RSSS | concentrated, healthcare, Manufacturing, Publishing, small caps, value | Fund focuses exclusively on small- and micro-cap companies that can grow over time, targeting 15% annualized returns. Manager emphasizes differentiated strategy versus indices which are overly represented by unprofitable, speculative companies. Portfolio concentrated in top five positions representing 60% of assets. | QRHC PESI RSSS MTRX PDEX |
View |
| 2024 Q3 | Oct 25, 2024 | Long Cast Advisers | 6.0% | 16.0% | AAPL, BANC, CCRD, ENVX, GS, JPM, MTRX, PDEX, PESI, QRHC, SNES | Concentration, Medical Devices, payments, small caps, value | PDEX is a contract manufacturer to the medical device industry with a marquee torque limiting driver for orthopedic and maxillofacial surgeries. The company recently completed manufacturing expansion and now has capacity for $80M-$100M in sales, up from under $40M in FY21. Management is patient and thoughtful with a long-term approach. | CCRD PDEX |
View |
| 2025 Q4 | Jan 24, 2026 | Long Cast Advisers | 1.0% | 0.0% | CCRD, CCRN, EEFT, LSYN, MAMA, MTRX, NRC, PDEX, PESI, QRHC, RELL, RSSS | healthcare, Owner-Operator, small caps, Staffing, value | Significant focus on healthcare staffing through CCRN investment, with nurse staffing industry facing competitive pressures but potential for margin improvement. Also invested in NRC, a healthcare consulting and patient survey company with strong margins despite industry headwinds. Portfolio concentrated in small and micro-cap companies with intent to own for multiple years. Manager emphasizes patient capital approach targeting 15% annualized returns through well-researched small company investments. Focus on companies trading at attractive valuations with strong balance sheets and cash positions. CCRN example shows investment in company with 40% of market cap in cash and low enterprise value multiples. | RSSS MTRX NRC CCRN |
View |
| 2024 Q4 | Jan 24, 2025 | Long Cast Advisers | 20.0% | 39.0% | CCRD, MTRX, PDEX, PESI, QRHC, RSSS | Concentration, Industrial, Microcap, Price Discovery, small caps, value | Manager focuses exclusively on small company investing, seeking five-year doubles with 15% annualized returns. Portfolio concentrated in top-five positions representing 70% of assets. Believes small cap managers handily beat relevant indices due to over-representation of unprofitable lottery tickets in benchmarks and sparse analyst coverage creating opportunities. | PESI QRHC MTRX RSSS PDEX CCRD |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Fund Letters | Long Cast Advisers | Quest Resource Holding Corporation | Industrials | Environmental & Facilities Services | Neutral | NASDAQ | Board Governance, cash flow generation, environmental services, Leverage Issues, Management Change, microcap, turnaround, waste management | View Pitch |
| Apr 13, 2026 | Fund Letters | Long Cast Advisers | Quest Resource Holding Corporation | Industrials | Environmental & Facilities Services | Neutral | NASDAQ | Customer Additions, EV Policy, Farm Recession, Industrial Headwinds, Recycling Services, Technology Transition, waste management | View Pitch |
| Apr 13, 2026 | Fund Letters | Long Cast Advisers | Quest Resource Holding Corporation | Industrials | Environmental & Facilities Services | Neutral | NASDAQ | Customer concentration, EV Policy, Farm Recession, Industrial Headwinds, management communication, Technology Transformation, waste management | View Pitch |
| Jan 8, 2026 | Fund Letters | Avram Fisher | Quest Resource Holding Corporation | Industrials | Environmental & Facilities Services | Bull | NASDAQ | Activism, cash flow, microcap, turnaround, waste management | View Pitch |
| Nov 28, 2025 | Fund Letters | Avram Fisher | Quest Resource Holding Corporation | Industrials | Environmental & Facilities Services | Bull | NASDAQ | ESG, Impairment, Recycling, services, Smallcap, turnaround, waste | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| Israel Englander | Millennium Management LLC | $233.2B | $172,132 | 0.00% | 92,544 | -14,329 | -13.41% | 0.4600% |
| David Siegel & John Overdeck | Two Sigma Investments | $67.5B | $104,128 | 0.00% | 55,983 | +55,983 | +100.00% | 0.2783% |